tiprankstipranks
Advertisement
Advertisement

ENTA Stock Latest News

Enanta announces first participant dosed in Phase 1 trial of EDP-978
The FlyEnanta announces first participant dosed in Phase 1 trial of EDP-978
3d ago
ENTA
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
PremiumCompany Announcements
Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case
21d ago
8K
ENTA
Enanta initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Enanta initiated with a Buy at Rodman & Renshaw
21d ago
ENTA
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
PremiumCompany Announcements
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
28d ago
ENTA
Enanta Shareholders Approve Board Elections and Equity Plan
PremiumCompany Announcements
Enanta Shareholders Approve Board Elections and Equity Plan
1M ago
8K
ENTA
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
PremiumRatingsEnanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
2M ago
ENTA
Enanta files $150M mixed securities shelf
Premium
The Fly
Enanta files $150M mixed securities shelf
2M ago
ENTA
Enanta reports Q1 EPS (42c), consensus (88c)
Premium
The Fly
Enanta reports Q1 EPS (42c), consensus (88c)
2M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
2M ago
ENTA
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
Enanta Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
5M ago
ENTA
Enanta Pharmaceuticals Reports Progress in Drug Development
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Progress in Drug Development
5M ago
ENTA
Enanta reports Q4 EPS (87c), consensus ($1.01)
PremiumThe Fly
Enanta reports Q4 EPS (87c), consensus ($1.01)
5M ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-EarningsIs ENTA a Buy, Before Earnings?
5M ago
ENTA
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
Premium
Ratings
Buy Rating for Enanta Pharmaceuticals Driven by Promising RSV Drug Pipeline and Market Potential
5M ago
ENTA
Enanta initiated with an Overweight at JPMorgan
Premium
The Fly
Enanta initiated with an Overweight at JPMorgan
5M ago
ENTA
Enanta Pharmaceuticals Announces Public Stock Offering
PremiumCompany Announcements
Enanta Pharmaceuticals Announces Public Stock Offering
7M ago
8K
ENTA
Enanta upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Enanta upgraded to Buy from Hold at Jefferies
7M ago
ENTA
Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
PremiumThe Fly
Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
7M ago
ENTA
Enanta 6.5M share Spot Secondary priced at $10.00
PremiumThe Fly
Enanta 6.5M share Spot Secondary priced at $10.00
7M ago
ENTA
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
PremiumThe FlyClosing Bell Movers: Nike rallies 4% after earnings beat and guidance
7M ago
AIR
COP
Enanta $50M Spot Secondary; price range $10.00-$10.50
Premium
The Fly
Enanta $50M Spot Secondary; price range $10.00-$10.50
7M ago
ENTA
Enanta announces $50M common stock offering
Premium
The Fly
Enanta announces $50M common stock offering
7M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >